Diagnostics / News

Diagnostics News

Filtered:

Transplantation (Remove filters)

BioPorto receives Frost & Sullivan Award

Frost & Sullivan awards AKI Product Leadership Award to BioPorto

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

Product launch - Human NGAL monomer-specific ELISA

BioPorto launches the first human NGAL monomer specific assay. 

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity, AKI treatment, Other
Date

Acute Kidney Biomarkers in focus in renown clinical issue

American Association for Clinical Chemistry (AACC) push for AKI biomarkers including NGAL in new cover story

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

The NGAL Test™ now launched for diagnostic use in Europe

BioPorto has CE-marked and is now launching The NGAL Test™ for diagnostic use in Europe.

Read more
Category
Diagnostics
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

The NGAL Test presented at BRS

BioPorto Diagnostics is proud to announce a scientific poster presentation at the BRS/RA Conference in Manchester that includes data obtained with The NGAL Test...

Read more
Category
Diagnostics, Congress news
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

The NGAL Test presented at ISICEM

BioPorto Diagnostics announces the presentation of a new scientific study that includes data obtained with The NGAL Test - the company's forthcoming diagnostic test for acute kidney injury...

Read more
Category
Diagnostics, Congress news
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date